536.19
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $536.19, with a volume of 2.15M.
It is down -0.55% in the last 24 hours and up +9.95% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$539.17
Open:
$538.13
24h Volume:
2.15M
Relative Volume:
0.89
Market Cap:
$202.47B
Revenue:
$43.21B
Net Income/Loss:
$6.58B
P/E Ratio:
31.04
EPS:
17.2769
Net Cash Flow:
$6.17B
1W Performance:
+1.03%
1M Performance:
+9.95%
6M Performance:
+27.87%
1Y Performance:
-9.95%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TMO
Thermo Fisher Scientific Inc
|
536.19 | 203.60B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
204.96 | 149.49B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
629.91 | 50.19B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
140.81 | 39.28B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
200.60 | 34.15B | 15.70B | 1.24B | 2.01B | 6.9036 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
Aug-19-25 | Initiated | William Blair | Outperform |
Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
Jul-09-25 | Downgrade | UBS | Buy → Neutral |
Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
Dec-23-24 | Initiated | Scotiabank | Sector Perform |
Oct-14-24 | Initiated | Redburn Atlantic | Buy |
Oct-01-24 | Initiated | Stephens | Overweight |
Aug-28-24 | Initiated | Wells Fargo | Overweight |
Jun-03-24 | Resumed | Jefferies | Buy |
Mar-18-24 | Resumed | Citigroup | Neutral |
Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
Dec-18-23 | Initiated | HSBC Securities | Buy |
Dec-13-23 | Initiated | Wolfe Research | Outperform |
Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Sep-28-23 | Initiated | Bernstein | Outperform |
Sep-06-23 | Resumed | Citigroup | Buy |
Jul-19-23 | Initiated | Raymond James | Outperform |
Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
Apr-04-23 | Reiterated | Barclays | Overweight |
Dec-14-22 | Initiated | Deutsche Bank | Buy |
Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
Aug-25-22 | Initiated | Credit Suisse | Neutral |
Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
Jan-26-22 | Resumed | Barclays | Overweight |
Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
Oct-15-21 | Resumed | Cowen | Outperform |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Jul-16-21 | Initiated | The Benchmark Company | Buy |
Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Mar-03-21 | Initiated | Barclays | Overweight |
Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
Dec-02-20 | Initiated | Goldman | Buy |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-30-20 | Initiated | Atlantic Equities | Overweight |
Sep-14-20 | Initiated | Morgan Stanley | Overweight |
Aug-20-20 | Resumed | JP Morgan | Overweight |
Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
Jul-07-20 | Reiterated | Needham | Buy |
Apr-23-20 | Reiterated | Needham | Buy |
Jan-31-20 | Reiterated | Needham | Buy |
Jan-22-20 | Initiated | Credit Suisse | Neutral |
Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
Jan-07-20 | Initiated | Citigroup | Buy |
Nov-15-19 | Initiated | Stifel | Buy |
Jul-25-19 | Reiterated | Needham | Buy |
Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
May-30-19 | Initiated | Wolfe Research | Outperform |
May-23-19 | Reiterated | Needham | Strong Buy |
Apr-22-19 | Reiterated | Needham | Strong Buy |
Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Maryland State Retirement & Pension System Buys 496 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Bleeding Disorder Diagnostics Market Global Forecast 2025-2032: Key Opportunities Through Digital Integration, AI-driven Analytics, and Expanded Point-of-care Testing - GlobeNewswire Inc.
Thermo Fisher Scientific Inc. $TMO Shares Bought by Sax Wealth Advisors LLC - MarketBeat
Thermo Fisher Scientific’s Valuation: Assessing the Impact of Its $1 Billion Vaxcyte Vaccine Manufacturing Deal - Yahoo Finance
WilmerHale Advises Thermo Fisher on $2.5 Billion Offering of Senior Notes - WilmerHale
Diagnostic System to Aid in Evaluation of Lung Transplant Rejection - Business Wire
Thermo Fisher Scientific Introduces New Molecular Microscope® Diagnostic System to Aid in Evaluation of Lung Transplant Rejection - The Joplin Globe
Navera Investment Management Ltd. Grows Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Hall Capital Management Co. Inc. Has $1.98 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Rothschild & Co Redburn Adjusts PT on Thermo Fisher Scientific to $575 From $525, Maintains Buy Rating - MarketScreener
Thermo Fisher Scientific Inc. $TMO Shares Sold by NBT Bank N A NY - MarketBeat
Mirova US LLC Sells 101,873 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Louisiana State Employees Retirement System Lowers Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Canopy Partners LLC - MarketBeat
Roundview Capital LLC Has $1.54 Million Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock - sharewise.com
Thermo Fisher Scientific (TMO) Announces $2.5 Billion Senior Not - GuruFocus
Thermo Fisher Scientific Experiences Evaluation Revision Amid Fluctuating Market Indicators - Markets Mojo
Thermo Fisher Scientific issues $2.5 billion in senior notes in public offering - Investing.com
Thermo Fisher Issues $2.5 Billion in Senior Notes - TipRanks
Thermo Fisher Scientific Leads Market Momentum in S&P 500 - Kalkine Media
Thermo Fisher Scientific (NYSE:TMO) Given New $590.00 Price Target at Evercore ISI - MarketBeat
Evercore ISI Group Raises Price Target for Thermo Fisher Scienti - GuruFocus
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $590 From $525, Maintains Outperform Rating - MarketScreener
KLP Kapitalforvaltning AS Has $57.90 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Duncan Williams Asset Management LLC Takes $206,000 Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
U.S. Cryo Electron Microscopy Market to Witness Massive Growth - openPR.com
Why Top Investors Are Buying Thermo Fisher Scientific Inc. (TMO) - The Acquirer's Multiple
Thermo Fisher Scientific Hits Day High with 3.5% Surge in Stock Price - Markets Mojo
What Does Thermo Fisher’s Recent 17.6% Surge Mean for Investors in 2025? - simplywall.st
How Thermo Fisher Scientific Inc. stock performs in weak economyDay Trade & Expert Approved Trade Ideas - newser.com
Thermo Fisher Launches Next-Gen In-Stream Analyzers for Safer, Smarter Slurry Elemental Analysis - AZoMining
Prime Capital Investment Advisors LLC Sells 6,928 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Wormser Freres Gestion Acquires 5,475 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
How Thermo Fisher Scientific Inc stock moves in volatile trading sessionsWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
Top Companies in Biobanking MarketThermo Fisher Scientific - openPR.com
Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub - BioSpectrum Asia
Marietta Wealth Management LLC Boosts Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Can Thermo Fisher Scientific Inc. recover in the next quarterMarket Rally & Weekly Stock Performance Updates - newser.com
Ascent Group LLC Trims Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Jim Cramer on Thermo Fisher: “They Really Got Hurt By COVID” - MSN
Hudson Valley Investment Advisors Inc. ADV Buys 1,058 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Acquired by ZWJ Investment Counsel Inc. - MarketBeat
Hilltop National Bank Takes Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MSN
Vaxcyte’s Strategic Moves: Impact on PCVX - StocksToTrade
Why Thermo Fisher (TMO) Stock Is Trading Up Today - TradingView
Vector Purification Market Research, Industry Trends & Global Forecasts, 2035, Profiles of Agilent, BIA Separations, Bio-Rad, BioVision, Cytiva, Merck, Sartorius, Takara Bio, Thermo Fisher ScientificResearchAndMarkets.com - Business Wire
KeyBanc Maintains Thermo Fisher Scientific(TMO.US) With Hold Rating - 富途牛牛
KeyBanc maintains Sector Weight rating on Thermo Fisher stock amid mixed segment performance - Investing.com
Thermo Fisher ups the accuracy on elemental analysis - International Mining
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):